Characteristics and Cytotoxic Effects of Nano-Liposomal Paclitaxel on Gastric Cancer Cells.

Gastric cancer Liposomal nanoparticle Nano drug delivery Paclitaxel

Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
01 09 2023
Historique:
received: 20 07 2023
medline: 29 9 2023
pubmed: 29 9 2023
entrez: 29 9 2023
Statut: epublish

Résumé

Addressing both the initial treatment response and subsequent paclitaxel resistance is a pivotal concern. Nano drug delivery, an emerging approach, presents a cutting-edge alternative to conventional chemotherapy. This investigation synthesized PEGylated nanoparticles (NPs) via the Reverse Phase Evaporation technique for liposomal NPs. Characteristics such as zeta potential, size, drug release and polydispersity index (PDI) were subjected to evaluation. Subsequently, cytotoxicity assays were conducted on gastric cancer cells (AGS) following 24 and 48-hour incubation periods. In this study, the liposomal NPs had a zeta potential of -22 mV and a particle size of 285 nm. The Entrapment efficiency was determined as 41% that occurred physically. Additionally, the liposomal NPs demonstrated a high drug retention rate (39% remained after 72 hours), and they exhibited significantly increased cytotoxicity compared to the free drug, confirming their effectiveness as a suitable carrier for paclitaxel during both incubation periods (P<0.05). These findings collectively advocate the potential of liposomal NPs as promising contenders for effective nano-drug application in propelling chemotherapy forward.

Identifiants

pubmed: 37774084
doi: 10.31557/APJCP.2023.24.9.3291
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3291-3296

Auteurs

Zahra Abedi Cham Heidari (Z)

Department of Nursing, Karaj Branch, Islamic Azad University, Karaj, Iran.

Parizad Ghanbarikondori (P)

Department of Pharmaceutics, Pharmaceutical Sciences Branch, Islamic Azad University (IAU), Tehran, Iran.

Elham Mortazavi Mamaghani (E)

Department of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Ali Hheidari (A)

Department of Mechanical Engineering, Islamic Azad University, Science and Research Branch, Tehran, Iran.

Elham Saberian (E)

MDDr., PhD and Specialty Student, Pavol Jozef Safarik University, Klinika Bacikova, Kosice, Slovakia.

Elaheh Mozaffari (E)

Department of Neurology, School of Medicine, Boushehr University of Medical Sciences, Boushehr, Iran.

Mohsen Alizadeh (M)

Department of Chemistry Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Mohammadreza Allahyartorkaman (M)

Department of life Science, College of Life Science, National Taiwan University, Taipei, Taiwan.

Classifications MeSH